文献速递妇产影像技术与安全US

三维超声诊断子宫腺肌症与单囊胚解冻移植后不良妊娠结局无关:前瞻性队列研究

Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

前瞻性队列纳入648例接受单囊胚解冻移植者,移植前日行三维超声并由5位专家独立评估7项腺肌症超声特征。腺肌症超声患病率15.3%(99/648),与无腺肌症者相比临床妊娠率(80.0% vs 75.0%)和活产率(69.5% vs 66.5%)相似。作者认为无症状腺肌症的超声标志物可能不改变妊娠结局,常规筛查可能不必要。

要点

  • 腺肌症超声患病率15.3%(99/648),多数腺肌症患者回顾性病历复习无明显症状。
  • 5位专家三维超声评估腺肌症间信度差(κ=0.23),内信度中等(κ=0.58)。
  • 校正混杂后,腺肌症与临床妊娠(aOR 1.47,95%CI 0.85-2.56)、流产(aOR 1.3,95%CI 0.62-2.72)和活产(aOR 1.28,95%CI 0.78-2.08)无显著关联。

关键影像表现/征象

  • 评估的7项腺肌症超声特征包括:子宫整体增大、肌层壁不对称、回声不均匀、结合带不规则、肌层囊肿、扇形声影和肌层边界不清病变。
  • 多数评估者认为存在至少一项特征即诊断为腺肌症,超声患病率15.3%(99/648)。

诊断标准与关键数值

  • 腺肌症诊断标准:多数评估者注意到7项超声特征中至少一项即认为存在腺肌症。
  • 间信度差(κ=0.23),内信度中等(κ=0.58)。
  • 临床妊娠率腺肌症组80.0% vs 无腺肌症组75.0%,校正后aOR 1.47(95%CI 0.85-2.56)。
  • 活产率腺肌症组69.5% vs 无腺肌症组66.5%,校正后aOR 1.28(95%CI 0.78-2.08)。
  • 流产率校正后aOR 1.3(95%CI 0.62-2.72)。

临床应用与阅片要点

  • 在无症状不孕人群行冻胚移植前,三维超声诊断的腺肌症超声标志物似乎不改变妊娠结局,常规筛查可能不必要。
  • 三维超声评估腺肌症的间信度差,阅片时需注意观察者间差异。

局限性

  • 腺肌症评估的间信度差(κ=0.23)。
  • 研究结论基于无症状患者,可能不适用于有症状人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The objectives of this study were (1) to assess the prevalence of ultrasound (US) features of adenomyosis in an infertile population undergoing in-vitro fertilization (IVF), (2) to define the inter- and intrarater agreement of three-dimensional (3D) US assessment of adenomyosis, and (3) to evaluate sonographic features of adenomyosis with respect to pregnancy outcome following transfer of a single thawed euploid blastocyst.

METHODS: This was a prospective cohort study. Subjects scheduled to undergo a single thawed euploid blastocyst transfer between April and December 2017 at a large IVF center were eligible for inclusion. Enrolled subjects underwent endometrial preparation for frozen embryo transfer. 3D-US was performed on the day prior to embryo transfer, with images stored for subsequent evaluation. Subjects then underwent transfer of a single thawed euploid blastocyst, and pregnancy outcomes were collected. All 3D-US volumes were de-identified and reviewed independently by five reproductive endocrinologists/infertility specialists with expertise in gynecological US for the presence of seven sonographic features of adenomyosis: global uterine enlargement, myometrial wall asymmetry, heterogeneous echogenicity, irregular junctional zone, myometrial cysts, fan-shaped shadowing and ill-defined myometrial lesions. Adenomyosis was considered to be present if the majority of the reviewers noted at least one of the seven sonographic features. Inter- and intrarater agreement was evaluated using Fleiss's kappa. Clinical and cycle characteristics of subjects with and those without adenomyosis were compared. The primary outcome of interest was live birth rate. Secondary outcomes included clinical pregnancy rate and miscarriage rate. Logistic regression analysis was performed to account for potential confounders.

RESULTS: A total of 648 subjects were included. The prevalence of adenomyosis on US was 15.3% (99/648). On retrospective chart review, very few patients with adenomyosis had symptoms. The inter- and intrarater agreement amongst five independent specialists conducting the 3D-US assessments of adenomyosis were poor (κ = 0.23) and moderate (κ = 0.58), respectively. Subjects with adenomyosis were older (37.1 vs 35.9 years, P = 0.02) and more likely to undergo a gonadotropin-releasing hormone agonist downregulation protocol when compared with those without adenomyosis (12.1% vs 5.1%, P = 0.02). Clinical pregnancy (80.0% vs 75.0%) and live birth (69.5% vs 66.5%) rates were similar between the groups. When adjusting for potential confounders, there was no difference in the rate of clinical pregnancy (adjusted odds ratio (aOR), 1.47 (95% CI, 0.85-2.56)), miscarriage (aOR, 1.3 (95% CI, 0.62-2.72)) or live birth (aOR, 1.28 (95% CI, 0.78-2.08)) between subjects with and those without adenomyosis. No individual sonographic marker of adenomyosis was predictive of pregnancy outcome.

CONCLUSIONS: The inter-rater agreement of 3D-US assessment of adenomyosis is poor. Furthermore, sonographic markers of adenomyosis in asymptomatic patients may not be associated with altered pregnancy outcome following transfer of a single thawed euploid blastocyst. These findings suggest that routine screening for asymptomatic adenomyosis in an unselected infertile patient population undergoing frozen embryo transfer may not be warranted. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Neal S, Morin S, Werner M, et al. Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study. Ultrasound Obstet Gynecol. 2020. PMID: 32349167. doi:10.1002/uog.22065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。